Johnson & Johnson Live Stock Price Today, Share Analysis and Chart

Name: Johnson & Johnson: Is Infosys Ltd. worth buying?
Item: Johnson & Johnson
Rating: 2.351680625
Author: Trendlyne DVM scores

Turnaround Potential

about

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After...

243.04 -1.08 (-0.44%)

Near 52W High of $251.71

6.9M

XNYS Volume

XNYS 02 Apr, 2026 5:30 PM (EDT)

Board Meeting

The next board meeting for Johnson & Johnson is on 14 Apr 2026 for the purpose of Johnson & Johnson First Quarter Earnings Results for 2026 See details

Medium Financial Strength

38.9 / 100

Mid Valuation

41.2 / 100

Technically Moderately Bullish

69.2 / 100

Turnaround Potential These stocks have average financials and valuation, but strong momentum indicating buying interest View Similar Embed DVM

241

1Yr Price target downside is -1%

24 analysts

Johnson & Johnson Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Johnson & Johnson Live Stock Price Today, Share Analysis and Chart

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After...

Near 52W High of $251.71

SWOT Analysis

Johnson & Johnson Live Price Chart